Work

Early rebiopsy to identify mechanisms and biomarkers of tumor cell survival following epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps9100

Authors: Caroline Elizabeth McCoach, Dan Merrick, Dara L. Aisner, Paul A. Bunn, D. Ross Camidge, Dexiang Gao, Kimi Kondo, Robert Charles Doebele

Institutions: University of Colorado Anschutz, University of Colorado Denver

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889854829

Cites:

Cited by:

Related to: 10